Observational studyMedicine2018

Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysis.

So Yeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.